DLBCL | sciencenewsnet.in

Breaking News

Endocrine Society and European Society of Endocrinology publish joint guideline on glucocorticoid-induced adrenal insufficiency

Oppenheimer Fellows to Gain Broader View of National Labs

Negotiations for a Global Pandemic Agreement Extended

Daylight Saving Time Spells Bad News for Healthy Habits

Getting out of the political echo chamber

Agreement Signing on Authorization of Rights under Petty Patent regarding “Nanoparticle Encapsulated Hydrogel Composition for Essential Oils and Preparation Methods”

Agreement Signing on Authorization of Rights under Petty Patent regarding “Methods to Prepare Extracts with Antioxidants and Pectin from Unripe Durians”

Alarming Rise of Electronic Vaping Use in U.S. Adolescents

Intense Ultrasound Extracts Genetic Info for Less Invasive Cancer Biopsies #ASA186

Researchers create human aortic aneurysm model to advance disease understanding, treatment testing

13 May, 2024

NUS researchers develop novel approach for predicting resistance against cancer therapy

July 18, 2023 sarah JonasResearch Results

A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS), led by Assistant Professor Anand Jeyasekharan, has discovered a unique combination of oncogenes that could predict treatment resistance, and hence unfavourable outcomes, of patients with Diffuse large B cell lymphoma (DLBCL), the most common type of blood cancer in Singapore and globally.